Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results
ICosapent ethyl (IPE) added to statin therapy reduced initial CV events by 25% and total CV Events by 30% in the REDUCE-IT study. The study is the fir...
Deletion of fibroblast activation protein provides atheroprotection
Fibroblast activation protein (FAP) is upregulated at sites of tissue remodeling including chronic arthritis, solid tumors, and fibrotic hearts. It ha...
Differences in Management of Coronary Artery Disease in Patients With Medicare Advantage vs Traditional Fee-for-Service Medicare Among Cardiology Practices
One-third of Medicare beneficiaries are enrolled in Medicare Advantage (MA) Medicare Advantage incentivizes performance on evidence-based care. Study...
Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018
Across 26 current ACC/AHA guidelines, 8.5% of recommendations were classified as LOE A. When comparing current guidelines with prior versions, the pro...
Published Articles Reporting Studies by Industry Employees on Interventional Cardiology Devices
Findings were based on studies published between January 1, 2010, and December 31, 2012. Authors with IEAs were significantly more likely to report po...
Hypertension
Elevated cardiovascular risk including stroke, heart failure, and heart attack is present even after normalization of blood pressure in patients with...
Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients
Systemic hypertension is the most common comorbidity among cancer patients. Cancer and hypertension have common risk factors, have overlapping pathoph...
Role of the Peroxisome Proliferator Activated Receptors in Hypertension
Nuclear receptors represent a large family of ligand-activated transcription factors which sense the physiological environment. We will focus on the P...